“As part of our review, a detailed analysis of 30 reports of the formation of blood clots with a low platelet count, received by us before March 24, was carried out,” TASS reports.

It is noted that as of March 24, 18.1 million doses of the AstraZeneca vaccine were administered in the country.

"The benefits of vaccines against COVID-19 still outweigh any potential risks," the department said.

Earlier, the European Medicines Agency (EMA) announced that a possible link between coronavirus vaccination with a drug developed by AstraZeneca and the formation of blood clots has not been proven at the moment, but it is possible.